FDA Approved: KEPIVANCE — Supplemental Application (Swedish Orphan Biovitrum AB (publ))

View source ↗

Summary

FDA approved a supplemental application for KEPIVANCE (palifermin) filed by Swedish Orphan Biovitrum AB (publ), expanding its label for the prevention of severe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Oral Mucositis

Drugs mentioned

• Kepivance (Palifermin)

Snippet

SUPPL AP for KEPIVANCE (PALIFERMIN)